In Vivo Efficacy of ABHD17 Inhibition Validates the Palmitoylation Cycle as a Therapeutic Target in NRAS-Mutant Cancer
Year: 2026
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.6584066
Authors: Matthew Decker, Benjamin Huang, Timothy Ware, Christopher Boone, Michelle Tang, Julia Ybarra, Matthew J. Sale, Rony A. François, Aishwarya C. Ballapuram, Katrine A. Taran, Esteban Tarazona-Guzman, Pan-Yu Chen, Marcos Amendáriz, Camille J. Leung, Max Harris, Karensa Tjoa, Henry Hongo, Sydney Abelson, Jose M. Rivera, Johanna Virta, Nhi Ngo, Dylan M. Herbst, Radu M. Suciu, Carlos Guijas, Kimia Sedighi, Taylor Andalis, Elysia Roche, Boer Xie, Yunlong Liu, Catherine C. Smith, Michelle Arkin, Elliot Stieglitz, Frank McCormick, Micah J. Niphakis, Benjamin F. Cravatt, Kevin Shannon
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7154825271
Cites:
Cited by:
Related to: